Benovic J L, Onorato J J, Arriza J L, Stone W C, Lohse M, Jenkins N A, Gilbert D J, Copeland N G, Caron M G, Lefkowitz R J
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140.
J Biol Chem. 1991 Aug 15;266(23):14939-46.
The beta-adrenergic receptor kinase (beta ARK) specifically phosphorylates the agonist-occupied form of the beta-adrenergic and related G protein-coupled receptors. Structural features of this enzyme have been elucidated recently by the isolation of a cDNA that encodes bovine beta ARK. Utilizing a catalytic domain fragment of the beta ARK cDNA to screen a bovine brain cDNA library we have isolated a clone encoding a beta ARK-related enzyme which we have termed beta ARK2. Overall, this enzyme has 85% amino acid identity with beta ARK, with the protein kinase catalytic domain having 95% identity. The ability of beta ARK2 to phosphorylate various substrates was studied after expression in COS 7 cells. Although beta ARK2 is essentially equiactive with beta ARK in phosphorylating an acid-rich synthetic model peptide it was only approximately 50% as active when the substrate was the agonist-occupied beta 2-adrenergic receptor and only approximately 20% as active toward light-bleached rhodopsin. As with beta ARK, phosphorylation of the receptor substrates by beta ARK2 was completely stimulus dependent. RNA blot analysis with selected bovine tissues reveals an mRNA of 8 kilobases with a distribution similar to that of beta ARK. More detailed RNA analysis using a ribonuclease protection assay in various rat tissues suggests that the beta ARK2 message is present at much lower levels (typically 10-20%) than the beta ARK message. In the rat the beta ARK2 mRNA is localized predominantly in neuronal tissues although low levels are also observed in various peripheral tissues. The beta ARK2 gene has been localized to a region of mouse chromosome 5 whereas the beta ARK gene is localized on mouse chromosome 19. These data suggest the existence of a "family" of receptor kinases which may serve broadly to regulate receptor function.
β - 肾上腺素能受体激酶(βARK)特异性地磷酸化β - 肾上腺素能及相关G蛋白偶联受体的激动剂占据形式。最近通过分离编码牛βARK的cDNA阐明了该酶的结构特征。利用βARK cDNA的催化结构域片段筛选牛脑cDNA文库,我们分离出了一个编码与βARK相关酶的克隆,我们将其命名为βARK2。总体而言,该酶与βARK有85%的氨基酸同一性,蛋白激酶催化结构域有95%的同一性。在COS 7细胞中表达后研究了βARK2磷酸化各种底物的能力。尽管βARK2在磷酸化富含酸性的合成模型肽方面与βARK基本具有同等活性,但当底物是激动剂占据的β2 - 肾上腺素能受体时,其活性仅约为βARK的50%,而对光漂白视紫红质的活性仅约为βARK的20%。与βARK一样,βARK2对受体底物的磷酸化完全依赖于刺激。用选定的牛组织进行RNA印迹分析显示有一个8千碱基的mRNA,其分布与βARK相似。使用核糖核酸酶保护试验在各种大鼠组织中进行更详细的RNA分析表明,βARK2的信息水平比βARK信息低得多(通常为10 - 20%)。在大鼠中,βARK2 mRNA主要定位于神经组织,尽管在各种外周组织中也观察到低水平表达。βARK2基因已定位到小鼠染色体5的一个区域,而βARK基因定位在小鼠染色体19上。这些数据表明存在一个受体激酶“家族”,它们可能广泛地用于调节受体功能。